How to manage and get rid of Wegovy side effects

The biggest myth: side effects mean Wegovy isn't working for you

The most common thing people assume when nausea or stomach cramps hit is that something has gone wrong. It hasn't. Wegovy (semaglutide) slows the rate at which food leaves your stomach and acts on appetite centres in the brain — those same mechanisms are why the medicine works, and they are also why your gut needs time to adjust. Feeling queasy after your first injection is not a sign of an allergic reaction or a faulty pen. It is biology doing what the medicine asks of it.

What this means practically: the discomfort tends to be sharpest in the first week or two after starting, and again briefly each time the dose steps up. It is usually temporary. The NHS lists the most common Wegovy side effects as nausea, vomiting, diarrhoea, constipation, indigestion, burping and fatigue, a GI-led profile shared across this class of medicine. Headaches and dizziness appear too, though less often. None of this is trivial, but most people who stay the course find these effects settle as their body adjusts.

The myth worth correcting loudly is the idea that pushing through means going it alone. A prescriber who stays involved can slow a dose increase, discuss timing changes, or rule out something that needs attention. That clinical relationship is what separates a managed side-effect profile from a genuinely miserable experience.

Small changes that genuinely help with nausea and digestive symptoms

Evidence and clinical experience point to a handful of practical adjustments that make a consistent difference for most people. Eating smaller portions (and stopping before you feel completely full) gives a stomach that is already emptying slowly a better chance to cope. High-fat, very spicy or heavily processed meals tend to worsen nausea on semaglutide; plain, lower-fat options are easier. Eating slowly matters more on this medicine than it ever did before.

If you struggle with headaches alongside the GI symptoms, dehydration is often a factor. Nausea can quietly put you off drinking, which compounds the problem. Sipping water steadily through the day, rather than drinking large amounts at once, tends to sit better. Our page on managing Wegovy headaches covers this in more depth.

Timing your injection can help too. Some people find evening injections mean the worst nausea passes overnight. Others prefer mornings. There is no universally right answer, this is the kind of thing worth raising with your prescriber rather than experimenting with indefinitely, because the right time often depends on your own pattern of symptoms. If you want a deeper look at nausea specifically, the nausea guidance page goes further on this.

One thing that catches people out: picking up a new prescription just before a bank holiday, or ordering mid-December when delivery schedules shift. If a dose increase coincides with a week when support is harder to reach, knowing that in advance lets you plan. Our prescribers are available seven days a week, whatever the week brings.

When to stop managing symptoms yourself and get medical help

Most Wegovy side effects are uncomfortable, not dangerous. But some symptoms need prompt medical attention, and knowing which is which matters. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as a known, serious but infrequent risk with GLP-1 medicines: if you develop severe stomach pain that spreads to your back, with or without vomiting, stop the injection and seek medical help that day, do not wait to see if it settles. You can report suspected side effects directly to the MHRA via the Yellow Card scheme.

Signs of significant dehydration from prolonged vomiting or diarrhoea (dizziness when standing, very dark urine, not passing urine for hours) also warrant a call to 111 or your GP rather than home remedies. The same applies to any allergic reaction: hives, swelling of the face or throat, difficulty breathing.

Low mood or thoughts of self-harm are listed in the prescribing information as possible effects requiring attention. If your mental state changes after starting treatment, tell your prescriber or contact your GP. It is not a side effect to manage quietly.

None of this is meant to alarm. The clinical trial data (including the STEP 1 trial, published in the New England Journal of Medicine) involved tens of thousands of follow-up data points, and serious adverse events were uncommon. What the evidence supports is staying in contact with a prescriber, especially in the early weeks.

How to get Wegovy legally in the UK, with clinical support built in

Semaglutide for weight management is available only on prescription in the UK, a clinician must assess your history, weight, and any conditions before it is issued. There is no legal shortcut to that step. The risks of buying from unverified online sellers are well-documented: the MHRA has seized counterfeit weight-loss pens (including fake semaglutide products) and recorded hospitalisations linked to pens found to contain insulin rather than the stated medicine. Any seller offering Wegovy without a clinical assessment beforehand is not operating within UK law, and side-effect management without a prescriber involved is an entirely different risk again.

To verify any online pharmacy before using it, check the GPhC pharmacy register. At nume, our GPhC premises registration is 9012878, verifiable directly at pharmacyregulation.org. Our pharmacy sources through the licensed UK supply chain (Novo Nordisk authorised supply routes) so you receive genuine medicine, not an imitation.

The clinical route through nume is straightforward. You complete a free consultation; a named GPhC-registered Independent Prescriber reads your answers the same day; if treatment is suitable, your prescription is issued and your order dispatched before the end of the working day (order before 12pm). Side-effect management doesn't stop at dispatch: our team is available seven days a week, and if a dose needs adjusting, your prescriber reviews that properly rather than guessing. Every repeat order is clinically re-reviewed. No subscriptions, no auto-renewals.

Wegovy is licensed for adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure, high cholesterol, or type 2 diabetes. BMI alone doesn't determine suitability; your full medical picture does. Our guide to accessing Wegovy in the UK explains the full eligibility picture, and the Wegovy overview page covers how the medicine works, including how to dispose of your Wegovy pens safely once used. For broader options, the weight loss treatment overview is a good starting point.